Health & Pharm General

Queensland Bauxite Ltd (ASX:QBL) Andrew Kavasilas Interview Regarding Medical Cannabis Limited and Vitahemp

🕔5/24/2017 4:45:13 PM

Andrew Kavasilas, Technical Director of Medical Cannabis Limited (MCL), has been interviewed by 2Ser 107.3 in relation to the work that he has been doing with Medical Cannabis Limited and Vitahemp, and in preparation for the upcoming Hemp Health and Innovation Expo, Australia's largest Cannabis Expo. Andrew also discussed general information on the industry and Cannabis.

Read Full Article

Regeneus Ltd (ASX:RGS) Japanese Patent Office to Grant Key Patent for Progenza

🕔5/24/2017 9:20:35 AM

Regeneus (ASX:RGS), a clinical-stage regenerative medicine company, today announced that the Japanese Patent Office has issued a decision to grant a key patent covering the composition, manufacture and use of Progenza stem cell technology.

Read Full Article

Traditional Therapy Clinics Ltd (ASX:TTC) Company Update and Acquisition of Three Franchise Clinics

🕔5/23/2017 8:22:10 AM

Traditional Therapy Clinics Ltd (ASX:TTC) has successfully generated strong business and EBIT growth of more than 10% for its Chinese RMB operations since its IPO in 2015. This growth has been primarily generated by a careful expansion of both its franchised clinics and company owned clinics.

Read Full Article

Regeneus Ltd (ASX:RGS) Positive Clinical Trial Results for Progenza

🕔5/22/2017 9:52:04 AM

Regeneus (ASX:RGS), a clinical-stage regenerative medicine company, today announced positive results from its Phase 1 safety trial of Progenza in patients with knee osteoarthritis, meeting the primary endpoint of safety and tolerability.

Read Full Article

Rhinomed Ltd (ASX:RNO) May 2017 Investor Update - Delivering End to End Sleep Category Solutions

🕔5/16/2017 9:59:50 AM

Rhinomed Ltd (ASX:RNO) (OTCMKTS:RHNMF) are pleased to provide the Company's latest Investor Update for May 2017.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Receives Approval to Conduct Phase 2 Clinical Trial for Treatment of Multiple Sclerosis Symptoms

🕔5/15/2017 8:27:22 AM

MMJ PhytoTech Ltd (ASX:MMJ) is pleased to advise that its wholly-owned, Israeli-based subsidiary PhytoTech Therapeutics Limited, has received Helsinki and Ministry of Health approvals for the conducting of its Phase 2 clinical study into the safety and efficacy of its PTL201 capsules in treating spasticity related symptoms of multiple sclerosis patients.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Advances in Combatting Sleep Apnoea

🕔5/11/2017 2:01:36 PM

Treatment for sleep apnoea usually involves either a mask or a mouthguard. A new Australian invention combines the best elements of both. Brisbane dentist Chris Hart spent years struggling to sleep. He snored constantly. He often woke up during the night because he had stopped breathing because of a n obstruction in his nose and throat.

Read Full Article